Pulmozyme (dornase alfa, recombinant)

FDA posts safety alerts, public health advisories,press releases and other notices from companies as a service to health professionals, consumers and other interested parties. Although FDA approves medical products, FDA does not endorse either the product or the company.

This is the retyped text of a letter from Genentech, Inc. Contact the company for a copy of any referenced enclosures.

Attachment 1-

This recall affects ONLY the following lots of PulmozymeÒ (dornase alfa) Inhalation Solution NDC# 50242-0100-40

Lot Number	Expiration Date
H9706A	MAR 2000
H9708A	APR 2000
H9709A	APR 2000
H9710A	MAY 2000
H9711A	MAY 2000
H9715A	JUN 2000
H9716A	JUL 2000
H9720A	AUG 2000
H9721A	SEP 2000
H9727A	OCT 2000
H9730A	NOV 2000
H9731A	NOV 2000
H9732A	DEC 2000
K9702A	FEB 2001
K9703A	FEB 2001
K9704A	MAR 2001
K9707A	APR 2001
K9708A	MAY 2001
K9712A	JUN 2001
K9714A	JUL 2001
K9715A	AUG 2001
K9718A	AUG 2001
K9719A	AUG 2001

Genentech, Inc.
437 Kaufmann Court
South San Francisco, CA 94080